NCT07231120 2025-12-08A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer CachexiaJiangsu Nutai Biologics Co., LtdPhase 1 Recruiting54 enrolled